Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This study is designed to compare the efficacy and safety of two-weekly RAILIRI regimen with
FOLFIRI regimen in the treatment of advanced colorectal cancer patients in the second-line
setting.